GPC Biotech Schedules Conference Call on August 18th to Discuss First
Half 2009 Financial Results
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Martinsried/Munich (Germany) and Princeton, N.J., August 11, 2009 -GPC Biotech AG (Frankfurt Stock Exchange: GPC) today announced thatit will hold a conference call on Tuesday, August 18, 2009 to discussits financial results for the second quarter and first half of 2009.The results will be published on August 18th in advance of the call.Participants may listen via live webcast, accessible through the GPCBiotech Web site at www.gpc-biotech.com, or via telephone. A replaywill be available via the Web site following the live event. Thecall, which will be conducted in English, will be held on August 18at 15:00 CET/9:00 AM ET.The dial-in numbers for the call are as follows:Participants in Europe: 0049 (0) 696677757560044 (0)20 3003 2666Participants in the U.S.: 1-646-843-4608About GPC BiotechGPC Biotech AG is a publicly traded biopharmaceutical company focusedon developing anti-cancer drugs. The Company currently has twoprograms in clinical development: satraplatin, an oral platinumcompound, and RGB-286638, a multi-targeted protein kinase inhibitor.The Company's shareholders have approved a merger agreement pursuantto which the Company will combine its business with Agennix,Incorporated, a privately held biotechnology company located inHouston, Texas. Agennix is developing oral talactoferrin, a productcandidate that is currently in Phase 3 trials for non-small cell lungcancer. GPC Biotech AG is headquartered in Martinsried/Munich(Germany) and has a wholly owned U.S. subsidiary in Princeton, NewJersey. For additional information, please visit GPC Biotech's Website at www.gpc-biotech.com.This press release contains forward-looking statements, which expressthe current beliefs and expectations of the management of GPCBiotech. Such statements are based on current expectations and aresubject to risks and uncertainties, many of which are beyond ourcontrol, that could cause future results, performance or achievementsto differ significantly from the results, performance or achievementsexpressed or implied by such forward-looking statements. Actualresults could differ materially depending on a number of factors, andwe caution investors not to place undue reliance on theforward-looking statements contained in this press release.Forward-looking statements speak only as of the date on which theyare made and GPC Biotech undertakes no obligation to update theseforward-looking statements, even if new information becomes availablein the future.For further information, please contact:GPC Biotech AGInvestor Relations & Corporate CommunicationsPhone: +49 (0)89 8565-2693ir(at)gpc-biotech.comIn the U.S.: Laurie DoyleDirector, Investor Relations & Corporate CommunicationsPhone: +1 609-524-5884usinvestors(at)gpc-biotech.comAdditional media contacts for Europe:MC Services AGPhone: +49 (0) 89 210 228 0Raimund Gabrielraimund.gabriel(at)mc-services.euHilda Juhaszhilda.juhasz(at)mc-services.euAdditional investor contact for Europe:Trout International LLCLauren (Rigg) Williams, Vice PresidentPhone: +44 207 936 9325lrigg(at)troutgroup.com --- End of Message ---GPC Biotech AGFraunhoferstr. 20 Martinsried GermanyWKN: 585150; ISIN: DE0005851505; Index: CDAX, Prime All Share, TECH All Share, DAX;Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Regulierter Markt in Frankfurter Wertpapierbörse;
Datum: 11.08.2009 - 11:03 Uhr
Sprache: Deutsch
News-ID 4576
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 325 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GPC Biotech Schedules Conference Call on August 18th to Discuss First
Half 2009 Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von
GPC Biotech AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
